RHONDA GRECO: Open Payments
NPI 1962528711 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 17 payments from 11 companies in 2025. Trend: 2023 $416 · 2024 $556 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $143 |
| Janssen Biotech, Inc. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Genentech USA, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| JAZZ PHARMACEUTICALS INC. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
| ARRAY BIOPHARMA INC | 1 | $29 |
Products named: Dexcom G6 Transmitter, PLUVICTO, ERLEADA, Polivy, EPKINLY, KEYTRUDA, CALQUENCE, ZEPZELCA.
Industry payments across TX — which companies pay providers there.
